#Germany #Berlin #EU-GMP #Cantourage #Green Karat

Strengthening Cooperation in Europe's Medical Cannabis Market

On October 1, 2026, Green Karat, a trusted Canadian cannabis producer, acquired the esteemed EU-GMP certification, marking a significant milestone in its ongoing collaboration with Cantourage Group SE. This strategic partnership represents a crucial advancement in Cantourage's mission to serve as a leading platform for medical cannabis throughout Europe.

The Importance of EU-GMP Certification

EU-GMP stands for European Union Good Manufacturing Practice, a set of standards ensuring that products are consistently produced and controlled according to quality standards. This certification showcases Green Karat's commitment to manufacturing high-quality cannabis products that meet the stringent regulations of the European pharmaceutical market. By supporting Green Karat in the certification process, Cantourage solidifies its role as a key distribution partner in the EU and the UK for the premier cannabis products imported from Canada.

Enhancing Supply Chain Resilience and Flexibility

With the capability to import EU-GMP-certified finished products from Green Karat, Cantourage aims to increase the availability of premium cannabis offerings to pharmacies across Europe, thereby enhancing patient access after harvest. As stated by Philip Schetter, CEO of Cantourage, this collaboration not only strengthens access to high-quality products but also builds a more resilient supply chain, enabling them to respond flexibly to the market's demands.

Expanded Manufacturing Capacity

The partnership also paves the way for Cantourage to expand its manufacturing capacity. By shifting some production steps to certified cultivation partners, Cantourage increases flexibility, minimizing operational risks. This strategic shift equips Cantourage to operate on a broader scale efficiently, thus meeting rising demand for cannabis products in Europe.

Future Prospects and Collaborative Goals

Cantourage aims to grow its diversified product portfolio, enhancing its position as a certification partner and acting as a conduit for other international cannabis producers looking to enter the European market. Their collaborative approach with Green Karat exemplifies their overarching strategy to strengthen ties with top-quality cannabis producers and continually improve product offerings for a growing patient base across Europe.

Commitment to Quality and Patient Care

The trust between Cantourage and Green Karat is underscored by years of collaboration, combined with a deep understanding of regulatory landscapes and product quality. Cantourage’s focus on regulatory expertise remains pivotal as it emphasizes moving products to patients more quickly, ensuring that they receive the best possible care and outcomes from their medical cannabis treatments.

In conclusion, the EU-GMP certification for Green Karat represents not just a milestone in their partnership with Cantourage, but also signifies a vital step towards providing better access to high-quality medical cannabis for patients in need across the European market. As both companies continue to align their efforts, they remain committed to the overarching goal of improving patient care through superior cannabis products, paving the way for a more robust cannabis industry in Europe.

About Cantourage

Cantourage is a leading player in the European medical cannabis market. The company focuses on the production and distribution of cannabis preparations and cannabis-based pharmaceuticals, ensuring compliance with the highest European quality standards. By leveraging its